TRDA: Entrada Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 542.98
Enterprise Value ($M) 474.54
Book Value ($M) 269.37
Book Value / Share 8.48
Price / Book 2.02
NCAV ($M) 172.69
NCAV / Share 5.44
Price / NCAV 3.14

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 2.38
Current Ratio 2.38

Balance Sheet (mrq) ($M)
Current Assets 414.17
Assets 510.84
Liabilities 241.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 129.01
Operating Income -3.16
Net Income -6.68
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 139.80
Cash from Investing -138.40
Cash from Financing 21.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
06-26 13D/A Baker Bros. Advisors Lp 13.20 3.43
02-14 13G/A Price T Rowe Associates Inc /md/ 9.00 -0.16
02-14 13G/A Roche Finance Ltd 8.20 -2.47
02-14 13G/A Redmile Group, LLC 3.80 -30.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2023-08-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 7,232 63,848 11.33
2024-07-25 26,336 109,430 24.07
2024-07-24 12,339 119,092 10.36
2024-07-23 31,505 290,452 10.85
2024-07-22 11,270 68,474 16.46

(click for more detail)

Similar Companies
TKNO – Alpha Teknova, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc. TRVI – Trevi Therapeutics, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io